£20,000 study announced to investigate health risk to cancer nurses

Published: February 19th 2020.


An invitation to apply for a £20,000 research project investigating the health risk to nurses whilst they administer cancer treatments has been issued by The United Kingdom Oncology Nursing Society (UKONS).

The aim of the study is to evaluate the risks nurses face when they are exposed to cytotoxic drugs when treating patients.

UKONS say they are funding the research to support the cancer nursing community build on the findings and recommendations from a Cochrane Review that compared closed-system drug-transfer devices plus safe handling of hazardous drugs to safe handling alone.1

A requirement of the proposed study is to include direct (as opposed to proxy) primary outcome measure(s) to establish nurses’ risk of cytotoxic drug exposure when using current best practices for safe handling.

Secondary outcomes of the study, due for completion by the end of March 2022, may include comparing the effectiveness of current best practices for safe handling to safe handling plus additional safety measures, such as the use of closed-system drug-transfer devices.

The closing date for applications is 28th February 2020 and the grant will be awarded on 24th April.

For more information visit the UKONS website https://ukons.org/news-events/ukons-research-grant-call-for-applications/

  1. https://www.cochrane.org/CD012860/OCCHEALTH_closed-system-drug-transfer-devices-reducing-exposure-infusional-hazardous-medicines-healthcare